Latest Global Expansion News

Page 6 of 37
Neuren Pharmaceuticals reported a 15% rise in 2025 royalties from DAYBUE®, boosted by strong US sales and a new powder formulation launch. The company is progressing its pivotal Phase 3 trial for NNZ-2591 in Phelan-McDermid syndrome and reassessing capital management amid solid cash reserves.
Ada Torres
Ada Torres
27 May 2026
Australian Vintage Limited has locked in a $128 million refinancing deal extending to 2029 and reported a significant cash flow turnaround in FY26, driven by innovation and strategic acquisitions.
Victor Sage
Victor Sage
27 May 2026
Ionic Rare Earths (ASX: IXR) has secured binding agreements to supply critical rare earth oxides to US-based Advanced Magnet Lab, supporting domestic production of permanent magnets for defence applications under a US Defense Logistics Agency contract.
Maxwell Dee
Maxwell Dee
25 May 2026
SDI Limited has dispatched its Scheme Booklet to shareholders as it moves closer to a $1.40 per share acquisition by a Beijing Guoci subsidiary. The virtual shareholder meeting is set for 22 June 2026 with strong backing from the board and largest shareholder.
Ada Torres
Ada Torres
22 May 2026
AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.
Ada Torres
Ada Torres
21 May 2026
TruScreen Group Limited has kicked off a NZ$2.9 million capital raising combining a NZ$1 million placement and a NZ$1.94 million rights issue to fund its global expansion and regulatory compliance efforts. The company reported a 42% jump in product sales for FY2026 and is targeting major public health programs across 14 countries.
Ada Torres
Ada Torres
21 May 2026
AVITA Medical reported a 4% revenue increase in Q1 2026 with a narrowed net loss, underpinned by a new BARDA contract and promising Cohealyx clinical data. Leadership changes and regulatory approvals support a confident outlook.
Ada Torres
Ada Torres
15 May 2026
EBR Systems accelerated its U.S. commercial rollout of the WiSE CRT System in Q1 2026 with implant volumes more than doubling and revenue hitting US$2.4 million. The company also secured a key regulatory milestone in Australia with TGA Priority Review, yet losses deepened and cash burn intensified, raising fresh questions about its funding runway.
Ada Torres
Ada Torres
12 May 2026
Janus Electric has raised A$4.5 million through a discounted private placement, aiming to accelerate battery supply, truck production, and certification efforts across Australia and North America.
Victor Sage
Victor Sage
6 May 2026
Gentrack Group trims its FY26 revenue outlook amid strategic investments and signals a $20 million on-market share buyback post-H1 results.
Sophie Babbage
Sophie Babbage
5 May 2026
Vmoto Limited has inked a worldwide partnership with MotoGP Sports Entertainment Group to produce and distribute three MotoGP-branded electric scooter models, aiming to boost brand visibility and sales through 2030.
Victor Sage
Victor Sage
4 May 2026
X2M Connect is accelerating its transition to a high-margin SaaS model while trimming debt and growing its footprint across Asia-Pacific and the Middle East.
Sophie Babbage
Sophie Babbage
4 May 2026

Browse the archive

Full archive